{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:27:35Z","timestamp":1788301655063,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001697","name":"Keio University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jiac.2019.05.020","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T07:33:48Z","timestamp":1559979228000},"page":"972-978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Experimental verification of factors influencing calcium salt formation based on a survey of the development of ceftriaxone-induced gallstone-related disorder"],"prefix":"10.1016","volume":"25","author":[{"given":"Rui","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-0448","authenticated-orcid":false,"given":"Kazuaki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5934-0670","authenticated-orcid":false,"given":"Yuki","family":"Enoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2019.05.020_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00003495-198427060-00001","article-title":"Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use","volume":"27","author":"Richards","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2019.05.020_bib2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0960327116658108","article-title":"Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: a prospective study in 154 children","volume":"36","author":"Ustyol","year":"2017","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.jiac.2019.05.020_bib3","first-page":"182","article-title":"Ceftriaxone-associated acute gallbladder enlargement \u2013 an unexpected diagnosis in the child with urinary tract infection","volume":"19","author":"Krzemie\u0144","year":"2015","journal-title":"Dev Period Med"},{"key":"10.1016\/j.jiac.2019.05.020_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10396-008-0170-6","article-title":"A\u00a0symptomatic child with ceftriaxone-associated biliary pseudolithiasis","volume":"35","author":"Kutuya","year":"2008","journal-title":"J\u00a0Med Ultrason"},{"key":"10.1016\/j.jiac.2019.05.020_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbrc.2011.02.053","article-title":"Ceftriaxone crystallization and its potential role in kidney stone formation","volume":"406","author":"Chutipongtanate","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jiac.2019.05.020_bib6","first-page":"870","article-title":"Change upon mixing of Rocephin (R) (Ceftriaxone sodium) with Ca-containing electrolyte solution (Part 3) -Titration test and stirring test of Rocephin electrolyte solution using infusion pump","volume":"55","author":"Kobo","year":"2006","journal-title":"J\u00a0New Remedies Clin"},{"key":"10.1016\/j.jiac.2019.05.020_bib7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1248\/yakushi.129.1385","article-title":"Incompatibility of ceftriaxone sodium with calcium-containing products","volume":"129","author":"Nakai","year":"2009","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jiac.2019.05.020_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1248\/yakushi.130.95","article-title":"Prediction of incompatibility of ceftriaxone sodium with calcium ions using the ionic product","volume":"130","author":"Nakai","year":"2010","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.jiac.2019.05.020_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1248\/bpb.b16-00765","article-title":"Factorial analysis of hepatitis B virus reactivation-induced hepatitis B using JADER","volume":"40","author":"Hara","year":"2017","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jiac.2019.05.020_bib10","first-page":"975","article-title":"Examination of the drug concentration in the gallbladder tissue and the bile at 24 hours after ceftriaxone (CTRX) administration in chemotherapy for biliary tract infections","volume":"45","author":"Ono","year":"1996","journal-title":"J\u00a0New Remedies Clin"},{"key":"10.1016\/j.jiac.2019.05.020_bib11","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2957\/kanzo.27.1714","article-title":"Determination of biliary ionized Ca2+ concentration and its aspect in human gallbladder bile","volume":"27","author":"Tamasawa","year":"1986","journal-title":"Kanzo"},{"key":"10.1016\/j.jiac.2019.05.020_bib12","first-page":"683","article-title":"Mechanism of bile secretion and bile composition","volume":"29","author":"Shoda","year":"2008","journal-title":"Tan to Sui"},{"key":"10.1016\/j.jiac.2019.05.020_bib13","first-page":"138","article-title":"Acids-, Factors affecting the ionized calcium concentration in human bile- Especially influences of bile","volume":"3","author":"Toshima","year":"1989","journal-title":"J\u00a0Jpn Biliary Assoc"},{"key":"10.1016\/j.jiac.2019.05.020_bib14","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/0016-5085(90)90486-K","article-title":"Pathogenesis of ceftriaxone-associated biliary sludge. In\u00a0vitro studies of calcium-ceftriaxone binding and solubility","volume":"99","author":"Shiffman","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jiac.2019.05.020_bib15","first-page":"63","article-title":"Ceftriaxone-induced pancreatitis in a pediatric patient: case report","volume":"22","author":"Ruggiero","year":"2010","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.jiac.2019.05.020_bib16","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/jpc.13235","article-title":"Risk factors, complications and outcome of cholelithiasis in children: a retrospective, single-centre review","volume":"52","author":"Tuna Kirsaclioglu","year":"2016","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.jiac.2019.05.020_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2169\/internalmedicine.52.9108","article-title":"Acute cholangitis associated with ceftriaxone therapy","volume":"52","author":"Tamai","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2019.05.020_bib18","first-page":"2004","article-title":"Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in Chinese children","volume":"38","author":"Meng","year":"2010","journal-title":"J\u00a0Int Med Res"},{"key":"10.1016\/j.jiac.2019.05.020_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jcu.20228","article-title":"Ceftriaxone-associated biliary pseudolithiasis in children","volume":"34","author":"Biner","year":"2006","journal-title":"J\u00a0Clin Ultrasound"},{"key":"10.1016\/j.jiac.2019.05.020_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/02841850510015983","article-title":"Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children","volume":"46","author":"Ozturk","year":"2005","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jiac.2019.05.020_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1620\/tjem.211.285","article-title":"Pseudolithiasis due to ceftriaxone treatment for meningitis in children: report of 8 cases","volume":"211","author":"Araz","year":"2007","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.jiac.2019.05.020_bib22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1592\/phco.2005.25.10.1389","article-title":"Biliary sludge and hyperbilirubinemia associated with ceftriaxone in an adult: case report and review of the literature","volume":"25","author":"Bickford","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2019.05.020_bib23","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1124\/dmd.107.019125","article-title":"Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of beta-lactam antibiotics","volume":"36","author":"Kato","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jiac.2019.05.020_bib24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2174\/1389200217666160629114449","article-title":"The role of drug transporters in the pharmacokinetics of antibiotics","volume":"17","author":"Hua","year":"2016","journal-title":"Curr Drug Metabol"},{"key":"10.1016\/j.jiac.2019.05.020_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1440-1746.1992.tb01496.x","article-title":"Gall-bladder sludge: lessons from ceftriaxone","volume":"7","author":"Kim","year":"1992","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jiac.2019.05.020_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1248\/cpb.60.429","article-title":"Comparison between original and generic versions of ceftriaxone sodium preparation for injection: compatibility with calcium-containing product","volume":"60","author":"Tange","year":"2012","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.jiac.2019.05.020_bib27","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pan.2013.05.011","article-title":"Intraductal acidosis in acute biliary pancreatitis","volume":"13","author":"Tak\u00e1cs","year":"2013","journal-title":"Pancreatology"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19301527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19301527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:00:13Z","timestamp":1761159613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19301527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1341321X19301527"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.05.020","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental verification of factors influencing calcium salt formation based on a survey of the development of ceftriaxone-induced gallstone-related disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}